paragon

14 items

February 21, 2023

Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
WAKIX® (pitolisant) Net Revenue Increased ~41% Year-over-Year [...]
January 12, 2023

Evozyne Creates AI Model with NVIDIA for Novel Protein Design, Expected to Accelerate Drug Development
– New AI model, co-developed by Evozyne [...]
January 11, 2023

Emalex Biosciences Publishes Phase 2b Results for Tourette Syndrome Candidate in Pediatrics
– Study data shows investigational new drug, [...]
January 11, 2023

Veteran Technology Executive Mike Gamson Named Evozyne CEO
– Gamson to set commercial direction, strengthen [...]
April 29, 2020

Congratulations to Harmony Biosciences for being ranked 8th on the Fortune Best Healthcare and Biopharma workplaces list
April 29, 2020 – Like all Paragon Biosciences companies, [...]
April 22, 2019

Paragon Biosciences Names James Robinson President and Chief Operating Officer
The newly-created position is the result of rapid [...]